Drug
Bmn 110 Weekly
Bmn 110 Weekly: highest development phase Phase 3, developed by BioMarin Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| BMN 110 Weekly NCT01275066 | Phase 3 | MPS IV A |
Latest
No recent events.
Follow Bmn 110 Weekly on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.